 | Up a level |
Nagler, Michael; Angelillo, Anne; Méan, M; Limacher, A; Abbal, C; Righini, M; Beer, J H; Osterwalder, J; Frauchiger, B; Aschwanden, M; Matter, C M; Kucher, N; Cornuz, J; Banyai, M; Husmann, M; Staub, D; Mazzolai, L; Hugli, O; Rodondi, Nicolas and Aujesky, Drahomir (2017). Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis, 15(11), pp. 2165-2175. Wiley-Blackwell 10.1111/jth.13810
